Here are some scary numbers.
In 2019, the annual methamphetamine-related death rate in Montana was 7.2 per 100,000 people, exceeding the national average of 5.7 per 100,000 people. Furthermore, over 65 percent of Child and Family Services Division substance-use related placements list methamphetamine as the primary drug.
However, there is another tool in the toolbox to help reduce the impact of opiod and methamphetamine abuse in Montana.
Zoe Bernard, Administrator of the Addictive and Mental Disorders Division of the Montana Department of Public Health and Human Services spoke to KGVO on Wednesday about a program with the acronym ‘TRUST’.
“The program is called TReatment of Users of STimulants or ‘TRUST’,” said Bernard. “It’s the first evidence based program for treating those who are using stimulants including methamphetamine. We’re pretty excited because Montana Medicaid has put a component of the trust program into our Medicaid waiver request to the federal government and if that is approved, we will be able to pay for TRUST for all Medicaid members across the state that need it.”
Bernard described the program.
“TRUST is an intensive outpatient treatment model and it has multiple components to it,” she said. “The ones that don’t surprise people so much are that Cognitive Behavioral Therapy